Sonoma Pharmaceuticals (SNOA) Debt/Assets Ratio: History & Chart

Sonoma Pharmaceuticals, Inc.(SNOA)

Drug Manufacturers - Specialty & Generic · Boulder, CO

$1.23+0.01 (+0.82%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories. Its comprehensive product line features: Epicyn: an antimicrobial cleanser for facial use. Levicyn: a prescription HOCl-based treatment formulated to ease the burning, itching, and pain associated with numerous dermatological issues. Celacyn gel: a topical HOCl-based prescription product engineered to facilitate efficient healing and management of both new and old scars. SebuDerm: designed to soothe the burning, itching, redness, scaling, and discomfort linked to seborrhea and seborrheic dermatitis. Acuicyn: an HOCl-based solution for alleviating ocular itch and inflammation, while also maintaining cleanliness around the eyes. Microcyn: a topical HOCl product family aimed at accelerating wound healing by combating a wide spectrum of pathogens, including antibiotic-resistant strains that can impede natural recovery. MicrocynAH: an HOCl-based solution specifically for animals, providing relief for common conditions like hot spots, scratches, skin rashes, post-surgical sites, and irritated skin to support healing. Microdacyn60: an oral care solution for treating infections of the mouth and throat. MucoClyns: suitable for emergency use and safe for application on mucous membranes, cuts, abrasions, burns, and other body surfaces. Endocyn: a series of solutions for root canal irrigation. Pediacyn: a hydrogel designed for atopic dermatitis. Ocucyn: a cleanser for eyelids and eyelashes. Gramaderm: for the topical treatment of mild to moderate acne. Nanocyn: a hospital-grade disinfectant. Sinudox: for nasal irrigation purposes. Originally incorporated in 1999 as Oculus Innovative Sciences, Inc., the company officially rebranded to Sonoma Pharmaceuticals, Inc. in December 2016. Its headquarters are located in Woodstock, Georgia.

Boulder, CO

10 employees

www.sonomapharma.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Amy Trombly

View full financials

SNOA Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

4.08%

DEBT TO ASSETS RATIO AVG TTM

4.70%

DEBT TO ASSETS RATIO AVG 3Y

3.45%

DEBT TO ASSETS RATIO AVG 5Y

4.31%

DEBT TO ASSETS RATIO AVG 10Y

4.38%

DEBT TO ASSETS RATIO AVG 15Y

5.05%

DEBT TO ASSETS RATIO AVG 20Y

6.35%

CURRENT VS TTM AVG

-13.08%

CURRENT VS 3Y AVG

+18.18%

CURRENT VS 5Y AVG

-5.30%

CURRENT VS 10Y AVG

-6.90%

CURRENT VS 15Y AVG

-19.18%

CURRENT VS 20Y AVG

-35.77%

SECTOR MEDIAN · HEALTHCARE

0.09%

median of 873 covered companies

CURRENT VS SECTOR MEDIAN

+4434.77%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Sonoma Pharmaceuticals, Inc. (SNOA)	$5.89M	4.08%	4.70%	3.45%	4.31%
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$5.92M	0.05%	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.83M	0.01%	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.82M	0.06%	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$5.73M	0.00%	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.70M	0.02%	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$6.11M	0.12%	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	0.00%	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.28M	0.39%	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$5.35M	0.02%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Sonoma Pharmaceuticals, Inc. (SNOA)

$5.89M

4.08%

4.70%

3.45%

4.31%

Cardio Diagnostics Holdings, Inc. (CDIO)vs ›

$5.92M

0.05%

N/A

Lucyd, Inc (LUCY)vs ›

$5.83M

0.01%

N/A

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›

$5.82M

0.06%

N/A

Enlivex Therapeutics Ltd. (ENLV)vs ›

$5.73M

0.00%

N/A

enVVeno Medical Corporation (NVNO)vs ›

$5.70M

0.02%

N/A

Scienture Holdings, Inc. (SCNX)vs ›

$6.11M

0.12%

N/A

Acurx Pharmaceuticals, Inc. (ACXP)vs ›

$5.63M

0.00%

N/A

Femasys Inc. (FEMY)vs ›

$6.28M

0.39%

N/A

Lexaria Bioscience Corp. (LEXX)vs ›

$5.35M

0.02%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The debt to assets ratio for SNOA stock is 4.08%.

Is Sonoma Pharmaceuticals, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 4.08% is in line with its 5-year average of 4.31%, near the low end of its 5-year range (0.87%–17.20%).

What is the TTM average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The TTM average debt to assets ratio for SNOA stock is 4.70%.

What is the 3Y average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The 3Y average debt to assets ratio for SNOA stock is 3.45%.

What is the 5Y average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The 5Y average debt to assets ratio for SNOA stock is 4.31%.

What is the 10Y average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The 10Y average debt to assets ratio for SNOA stock is 4.38%.

What is the 15Y average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The 15Y average debt to assets ratio for SNOA stock is 5.05%.

What is the 20Y average debt to assets ratio for Sonoma Pharmaceuticals, Inc. (SNOA)?

The 20Y average debt to assets ratio for SNOA stock is 6.35%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	4.08%
2026-03-31	6.03%
2025-12-31	4.81%
2025-09-30	3.86%
2025-03-31	2.23%
2024-12-31	0.87%
2024-09-30	1.78%
2024-06-30	3.07%
2024-03-31	4.12%
2023-12-31	2.63%
2023-09-30	3.83%
2023-06-30	4.12%
2023-03-31	5.23%
2022-12-31	3.49%
2022-09-30	5.17%
2022-06-30	5.55%
2022-03-31	7.25%
2021-12-31	6.25%
2021-09-30	7.49%
2021-06-30	17.20%
2021-03-31	17.85%
2020-12-31	10.87%
2020-09-30	11.11%
2020-06-30	10.35%
2020-03-31	5.84%
2019-12-31	6.66%
2019-09-30	8.26%
2019-06-30	9.35%
2019-03-31	3.29%
2018-12-31	1.20%
2018-09-30	2.22%
2018-06-30	2.87%
2018-03-31	2.88%
2017-12-31	2.03%
2017-09-30	2.21%
2017-06-30	2.32%
2017-03-31	1.61%
2016-12-31	0.22%
2016-09-30	0.84%
2016-06-30	0.58%
2016-03-31	0.83%
2015-12-31	0.00%
2015-09-30	0.00%
2015-06-30	0.25%
2015-03-31	0.58%
2014-12-31	0.05%
2014-09-30	0.04%
2014-06-30	0.32%
2014-03-31	0.71%
2013-12-31	0.50%
2013-09-30	12.29%
2013-06-30	12.79%
2013-03-31	15.40%
2012-12-31	13.17%
2012-09-30	19.18%
2012-06-30	30.16%
2012-03-31	41.32%
2011-12-31	36.01%
2011-09-30	32.89%
2011-06-30	31.59%
2011-03-31	29.37%
2010-12-31	30.10%
2010-09-30	18.97%
2010-06-30	17.02%
2010-03-31	3.07%
2009-12-31	2.16%
2009-09-30	2.08%
2009-06-30	4.15%
2009-03-31	6.15%
2008-12-31	13.29%
2008-09-30	12.99%
2008-06-30	10.86%
2008-03-31	9.42%
2007-12-31	16.73%
2007-09-30	14.43%
2007-06-30	36.84%
2007-03-31	29.97%
2006-12-31	82.65%
2006-09-30	46.02%
2006-03-31	6.07%
2005-03-31	21.57%

DATE

DEBT TO ASSETS RATIO

2026-06-30

4.08%

2026-03-31

6.03%

2025-12-31

4.81%

2025-09-30

3.86%

2025-03-31

2.23%

2024-12-31

0.87%

2024-09-30

1.78%

2024-06-30

3.07%

2024-03-31

4.12%

2023-12-31

2.63%

2023-09-30

3.83%

2023-06-30

4.12%

2023-03-31

5.23%

2022-12-31

3.49%

2022-09-30

5.17%

2022-06-30

5.55%

2022-03-31

7.25%

2021-12-31

6.25%

2021-09-30

7.49%

2021-06-30

17.20%

2021-03-31

17.85%

2020-12-31

10.87%

2020-09-30

11.11%

2020-06-30

10.35%

2020-03-31

5.84%

2019-12-31

6.66%

2019-09-30

8.26%

2019-06-30

9.35%

2019-03-31

3.29%

2018-12-31

1.20%

2018-09-30

2.22%

2018-06-30

2.87%

2018-03-31

2.88%

2017-12-31

2.03%

2017-09-30

2.21%

2017-06-30

2.32%

2017-03-31

1.61%

2016-12-31

0.22%

2016-09-30

0.84%

2016-06-30

0.58%

2016-03-31

0.83%

2015-12-31

0.00%

2015-09-30

0.00%

2015-06-30

0.25%

2015-03-31

0.58%

2014-12-31

0.05%

2014-09-30

0.04%

2014-06-30

0.32%

2014-03-31

0.71%

2013-12-31

0.50%

2013-09-30

12.29%

2013-06-30

12.79%

2013-03-31

15.40%

2012-12-31

13.17%

2012-09-30

19.18%

2012-06-30

30.16%

2012-03-31

41.32%

2011-12-31

36.01%

2011-09-30

32.89%

2011-06-30

31.59%

2011-03-31

29.37%

2010-12-31

30.10%

2010-09-30

18.97%

2010-06-30

17.02%

2010-03-31

3.07%

2009-12-31

2.16%

2009-09-30

2.08%

2009-06-30

4.15%

2009-03-31

6.15%

2008-12-31

13.29%

2008-09-30

12.99%

2008-06-30

10.86%

2008-03-31

9.42%

2007-12-31

16.73%

2007-09-30

14.43%

2007-06-30

36.84%

2007-03-31

29.97%

2006-12-31

82.65%

2006-09-30

46.02%

2006-03-31

6.07%

2005-03-31

21.57%

Debt to Assets Ratio: 4.08%

SNOA Debt to Assets Ratio

SNOA Average Debt to Assets Ratio Chart

SNOA Current vs Average Debt to Assets Ratio Chart

SNOA Debt to Assets Ratio Metrics

SNOA Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

SNOA Debt to Assets Ratio History

Related Metrics